Abstract:Abstract Disclosure: D. Kira: None. Z.A. Hawkins: None. L.P. Chorich: None. S. Brakta: None. L. Gan: None. L.C. Layman: None. Introduction: Zinc finger, HIT domain containing 3 (ZNHIT3), also known as thyroid hormone receptor-interacting protein 3 (TRIP-3), is a 155 amino acid protein with an N-terminus Zinc finger HIT domain (11-42a.a) that is involved in pre-ribosomal RNA processing. It also has a C-terminus short conserved LxxLL binding motif that interacts with the ligand binding domain of the thyroid receptor in the presence of thyroid hormone as a co-activator associated with hepatocyte nuclear factor-4α (HNF-4α). ZNHIT3 is localized to the cytoplasm and the nucleus. Biallelic ZNHIT3 pathogenic variants in the N-terminus have been identified in persons with Progressive encephalopathy with Edema, Hypsarrhythmia, and Optic atrophy (PEHO) syndrome, a severe autosomal recessive neurodevelopmental disorder characterized by extreme cerebellar atrophy due to almost total loss of granule neurons. Heterozygous pathogenic variants in ZNHIT3 affecting the C-terminus have been demonstrated in individuals with Mayer-Rokitansky-Küster-Hauser (MRKH). MRKH consists of the congenital absence of the uterus and vagina, either as isolated Mullerian aplasia (type 1) or associated with renal, skeletal, cardiac, and auditory anomalies (type 2). Previous studies of animal models utilizing morpholino injection-induced knockdown and CRISPR editing of znhit3 in zebrafish both showed cerebellar defects and microcephaly. We are not aware of a mouse model of Znhit3.Hypothesis: We hypothesize that the Znhit3 knockout (KO) mouse will demonstrate reproductive abnormalities and an MRKH-related phenotype. Methods: Heterozygous Znhit3 (Znhit3+/-) KO mice were generated by CRISPR. A 1 base deletion was introduced in exon 2, creating a frameshift and a stop codon in exon 3, which leads to a truncated protein. We then crossed male and female Znhit3+/- mice and Znhit3+/- and wild-type Znhit3+/+ (WT) mice. Pups' genotypes were confirmed with DNA sequencing of tail samples. Pups were weighed weekly from age 3 weeks to 16 weeks. Results: Mating 17 pairs of Znhit3+/- mice resulted in a total of 73 pups born, of which 50 were Znhit3+/- and, 23 were WT with a ratio of almost 2:1. No homozygous Znhit3 (Znhit3-/-) KO pups were born. There was no significant difference in weights between Znhit3+/- and WT pups. Conclusion: Heterozygous Znhit3+/- animals appeared to be phenotypically normal with similar weights to WT. However, the Hardy-Weinberg equilibrium (1 homozygous wild-type: 2 heterozygous: 1 homozygous variant) was disrupted, as no Znhit3−/− homozygotes were born, suggesting embryonic lethality. It is possible that central nervous system, cardiac, and/or renal defects could be responsible for this lethality, which will be studied in embryos at E18.5, 15.5, and 12.5. A detailed phenotypic characterization will be performed with regard to reproductive function and MRKH-related organ development. Presentation: Friday, June 16, 2023

FRI387 Reproductive Capacity Of Znhit3 Knockout Mouse Model

Novel Mutations in ZP1, ZP2, and ZP3 Cause Female Infertility Due to Abnormal Zona Pellucida Formation.

Heterozygous ZNHIT3 variants within the 17q12 recurrent deletion region are associated with Mayer-Rokitansky-Kuster Hauser (MRKH) syndrome

Overlapping peri-implantation phenotypes of ZNHIT1 and ZNHIT2 despite distinct functions during early mouse development

Mutant Zp1 Impedes Incorporation of ZP3 and ZP4 in the Zona Pellucida, Resulting in Zona Absence and Female Infertility in Rats

New ZNHIT3 Variants Disrupting snoRNP Assembly Cause Prenatal PEHO Syndrome with Isolated Hydrops

Loss of Zygotic NUP107 Protein Causes Missing of Pharyngeal Skeleton and Other Tissue Defects with Impaired Nuclear Pore Function in Zebrafish Embryos

Mutant Zp1 results in Zona Pellucida Lacking and Female Infertility in Rats and Humans

A Heterozygous Truncating Mutation in BNC1 Causes Male Subfertility: BNC1 Cooperates with TAF7L to Regulate Spermatogenesis

Mutant<i>Zp1</i>results in Zona Pellucida Lacking and Female Infertility in Rats and Humans

Dosage effects of ZP2 and ZP3 heterozygous mutations cause human infertility

Targeted Disruption of the Mouse Testis-Enriched Gene Znf230 Does Not Affect Spermatogenesis or Fertility.

Dysregulation of Grainyhead-like 3 expression causes widespread developmental defects

A heterozygous ZP2 mutation causes zona pellucida defects and female infertility in mouse and human

The chromatin-remodeling enzyme CHD3 plays a role in embryonic viability but is dispensable for early vascular development

A New Mutant Transcript Generated in Znf230 Exon 2 Knockout Mice Reveals a Potential Exon Structure in the Targeting Vector Sequence.

Identification of zona pellucida defects revealed a novel loss-of-function mutation in ZP2 in humans and rats

Znrf3 exon 2 deletion mice do not recapitulate congenital adrenal hypoplasia

ZC3H4-a novel Cys-Cys-Cys-His-type zinc finger protein-is essential for early embryogenesis in mice†

Deficiency of the Placenta- and Yolk Sac-Specific Tristetraprolin Family Member ZFP36L3 Identifies Likely Mrna Targets and an Unexpected Link to Placental Iron Metabolism.

Kcnh2 Deletion is Associated with Rat Embryonic Development Defects Via Destruction of KCNH2‑integrin Β1 Complex.